Table 2.
Population characteristics (n = 435).
| Characteristics | Values | |
|---|---|---|
| Age (years) | 71 (65–75) | |
| PSA at PET/CT (ng/mL), med (IQR) | 1.14 (0.5–3) | |
| PSAdt (months), med (IQR) | 6.7 (3.9–13) | |
| PSAvel (ng/mL/an), med (IQR) | 0.9 (0.3–2.8) | |
| pTstage, n (%) | ||
| T1c | 2 (0.5) | |
| T2a | 16 (3.7) | |
| T2b | 39 (9) | |
| T2c | 132 (30) | |
| T3a | 155 (36) | |
| T3b | 84 (19) | |
| Unknown | 7 (1.6) | |
| pN stage, n (%) | ||
| N1 | 40 (9.2) | |
| N0 | 222 (51) | |
| Nx | 173 (40) | |
| ISUP grade group, n (%) | ||
| 1 | 69 (16) | |
| 2 | 160 (37) | |
| 3 | 117 (27) | |
| 4 | 66 (15) | |
| 5 | 23 (5.3) | |
| Surgical margins, n (%) | ||
| R1 | 142 (33) | |
| R0 | 178 (41) | |
| Rx | 115 (26) | |
| Pelvic lymph node dissection, n (%) | ||
| Performed | 243 (56) | |
| Not performed | 126 (29) | |
| Unknown | 66 (15) | |
| Adjuvant RT, n (%) | 122 (28) | |
| Salvage radiotherapy, n (%) | 200 (46) | |
| BCR status, n (%) | ||
| First BCR | 235 (54) | |
| Salvage RT | 200 (46) | |
| EAU BCR risk group, n (%) | ||
| Low risk | 97 (22) | |
| High risk | 338 (78) | |
PSAdt: PSA doubling time; PSAvel: PSA velocity; ISUP: International Society of Urological Pathology; RT: Radiotherapy; BCR: Biochemical recurrence.